ALS2 Protein (Alsin)

ALS2 Protein (Alsin)

<div class="infobox infobox-protein">
<div class="infobox-header">ALS2 Protein (Alsin)</div>
<table class="infobox-table">
<tr><th>Protein</th><td>Alsin</td></tr>
<tr><th>Gene</th><td>ALS2</td></tr>
<tr><th>UniProt</th><td><a href="https://www.uniprot.org/uniprotkb/Q96Q42/entry" target="_blank" rel="noopener noreferrer">Q96Q42</a></td></tr>
<tr><th>Core Function</th><td>Rab5/Rac1 guanine-nucleotide exchange and endosomal trafficking control</td></tr>
<tr><th>Primary Localization</th><td>Cytosol with dynamic recruitment to endosomal and stress-responsive membranes</td></tr>
<tr><th>Disease Axis</th><td>Juvenile motor-neuron syndromes (juvenile ALS, PLS, IAHSP)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/dementia" style="color:#ef9a9a">Dementia</a>, <a href="/wiki/frontotemporal-dementia" style="color:#ef9a9a">Frontotemporal Dementia</a>, <a href="/wiki/ftd" style="color:#ef9a9a">Ftd</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">105 edges</a></td>
</tr>
</table>
</div>

Overview

ALS2 Protein (Alsin)

<div class="infobox infobox-protein">
<div class="infobox-header">ALS2 Protein (Alsin)</div>
<table class="infobox-table">
<tr><th>Protein</th><td>Alsin</td></tr>
<tr><th>Gene</th><td>ALS2</td></tr>
<tr><th>UniProt</th><td><a href="https://www.uniprot.org/uniprotkb/Q96Q42/entry" target="_blank" rel="noopener noreferrer">Q96Q42</a></td></tr>
<tr><th>Core Function</th><td>Rab5/Rac1 guanine-nucleotide exchange and endosomal trafficking control</td></tr>
<tr><th>Primary Localization</th><td>Cytosol with dynamic recruitment to endosomal and stress-responsive membranes</td></tr>
<tr><th>Disease Axis</th><td>Juvenile motor-neuron syndromes (juvenile ALS, PLS, IAHSP)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/dementia" style="color:#ef9a9a">Dementia</a>, <a href="/wiki/frontotemporal-dementia" style="color:#ef9a9a">Frontotemporal Dementia</a>, <a href="/wiki/ftd" style="color:#ef9a9a">Ftd</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">105 edges</a></td>
</tr>
</table>
</div>

Overview

Alsin, encoded by ALS2, is a multi-domain trafficking regulator that coordinates membrane dynamics in vulnerable long-projecting [neurons](/entities/neurons).[@hadano2001][@yang2001] Pathogenic biallelic ALS2 variants are a validated cause of juvenile-onset motor-neuron disorders, including juvenile amyotrophic lateral sclerosis, juvenile primary lateral sclerosis, and infantile ascending hereditary spastic paralysis.[@hadano2001][@yang2001][@panzeri2006]

Mechanistically, alsin is best characterized as a Rab5 pathway activator with additional Rac1-coupled behavior that links cytoskeletal signaling to endocytic flux.[@topp2004][@kunita2007] This places ALS2 at the interface of [endolysosomal trafficking defects](/mechanisms/endolysosomal-trafficking-defects), stress adaptation, and axonal maintenance.

Domain Architecture and Functional Logic

ALS2 is a large protein with an N-terminal RCC1-like region, central Dbl-homology/pleckstrin-homology features, and a C-terminal VPS9 domain that drives Rab5 activation.[@topp2004][@yamanaka2003] The domain organization supports a recruitment-and-activation model:

• upstream membrane/cytoskeletal cues recruit alsin,
• alsin locally activates Rab5,
• endosome maturation/fusion is promoted,
• trafficking competence is restored under stress.

Normal Cellular Function

Endosomal maturation and membrane turnover

ALS2 supports early endosomal dynamics through Rab5 activation and shapes macropinocytic/endocytic processing pathways.[@topp2004][@kunita2007] This function is particularly relevant in neurons, where membrane turnover and receptor recycling are continuous and spatially distributed.

Rac1-coupled membrane remodeling

ALS2 behaves as a Rac1-interacting effector under activated conditions, linking actin-dependent membrane remodeling to Rab5-positive vesicle handling.[@kunita2007] This coupling provides a mechanistic bridge between growth/motility cues and intracellular transport.

Stress-responsive mitochondria-endosome crosstalk

Under oxidative challenge, Rab5 machinery can relocalize to mitochondria in an ALS2-dependent manner, supporting a cytoprotective response. ALS2-deficient motor neurons show impaired adaptation and greater stress vulnerability.[@hsu2018]

Role in Disease

High-confidence genetic disease link

ALS2 mutations are among the clearest examples of recessive trafficking-pathway motor-neuron disease genes.[@hadano2001][@yang2001][@panzeri2006] The dominant molecular pattern is loss of function, often truncating variants.

Endolysosomal vulnerability model

Cell and animal models converge on impaired endosomal dynamics, altered neurite maintenance, and slowly progressive neuronal system dysfunction.[@yamanaka2003][@cai2005][@hadano2010] These models generally show subtle early phenotypes with cumulative late deficits, consistent with a long-horizon degeneration process rather than abrupt developmental failure.

Interaction with broader ALS stress biology

In SOD1-ALS background models, ALS2 loss worsens motor phenotypes, supporting the view that alsin functions as a resilience factor across convergent stress pathways rather than an isolated syndrome mechanism.[@hadano2010a]

Translational Implications

Near-term strategy: pathway compensation

Because ALS2 disease is mostly loss-of-function, immediate translational options are pathway compensation approaches:

• increasing endosomal efficiency,
• supporting mitochondrial stress buffering,
• reducing secondary inflammatory amplification.

Mid-term strategy: genetic restoration

Gene-replacement or RNA-level correction approaches are conceptually strong for ALS2 but require motor-system-wide delivery and dose control.

Trial-design considerations

ALS2-associated syndromes are rare and slowly progressive. Efficient clinical designs likely require:

• shared biomarker frameworks across juvenile motor-neuron disorders,
• longitudinal digital motor metrics,
• mechanistic endpoints tied to trafficking stress.

Evidence Quality Snapshot

• High confidence: ALS2 mutations cause recessive juvenile motor-neuron disease.[@hadano2001][@yang2001][@panzeri2006]
• High confidence: alsin is a Rab5-regulatory trafficking protein with Rac1-linked membrane dynamics.[@topp2004][@kunita2007]
• Moderate confidence: stress-induced mitochondria-endosome adaptation role relevant to motor-neuron survival.[@hsu2018]
• Moderate confidence: therapeutic leverage via endolysosomal pathway support, pending disease-specific intervention trials.

See Also

• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia)
• [Endolysosomal Trafficking Defects](/mechanisms/endolysosomal-trafficking-defects)
• [Mitochondrial Dysfunction Pathway](/mechanisms/mitochondrial-dysfunction-pathway)
• [RAB5A Protein](/proteins/rab5a-protein)

Brain Atlas Resources

The following resources from the Allen Brain Atlas provide expression and connectivity data for this protein/gene:

• [Allen Human Brain Atlas - Gene Expression](https://human.brain-map.org/microarray/search/show?search_term=ALS2): Searchable gene expression database from adult human brain
• [Allen Brain Atlas - RNA Sequencing](https://human.brain-map.org/rnasearch): RNA sequencing data across brain regions
• [Allen Cell Type Atlas](https://celltypes.brain-map.org/): Single-cell transcriptomic data for cell type classification
• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/): Comprehensive mouse brain gene expression database
• [BrainSpan Atlas of the Developing Human Brain](https://www.brainspan.org/): Developmental expression data across brain regions and ages

External Links

• [UniProt: als2](https://www.uniprot.org/)
• [PubMed: als2](https://pubmed.ncbi.nlm.nih.gov/?term=als2+neurodegeneration)

References

AlphaFold Structure

AlphaFold DB provides a predicted structure for ALS2 / UniProt Q96Q42 (model version 6): https://alphafold.ebi.ac.uk/entry/Q96Q42.
AlphaFold reports a mean pLDDT confidence score of 74.06, indicating confident backbone placement for much of the model, with lower-confidence regions possible.
InterPro annotations highlight Dbl homology domain domain (690-885); Regulator of chromosome condensation, RCC1 repeat (60-109); VPS9 domain domain (1513-1657).
PDB coordinates: https://alphafold.ebi.ac.uk/files/AF-Q96Q42-F1-model_v6.pdb mmCIF coordinates: https://alphafold.ebi.ac.uk/files/AF-Q96Q42-F1-model_v6.cif.
Use the prediction as structural context for target assessment; local low-pLDDT segments may reflect disorder, flexible linkers, or unresolved domain orientation rather than a stable fold.